Chemours (CC) is expected to deliver a year-over-year decline in earnings on lower revenues when it reports results for the quarter ended December 2024. This widely-known consensus outlook gives a good sense of the company's earnings picture, but how the actual results compare to these estimates is a powerful factor that could impact its near-term stock price.The earnings report, which is expected to be released on February 18, 2025, might help the stock move higher if these key numbers are better than expe ...

Group 1: Chemours Company (CC) - Analyst Peter Osterland initiated coverage with a Buy rating and a price forecast of $27, expecting strong earnings growth in 2025-2026 [1] - Margin expansion is anticipated in the Opteon refrigerant franchise, with a potential rebound in the TiO2 segment, where consensus estimates are seen as overly conservative [1] - Estimated EBITDA for 2024 is $775 million, for 2025 is $1.004 billion (+8% vs. Street), and for 2026 is $1.188 billion (+11% vs. Street) [2] Group 2: Tronox Holdings plc (TROX) - Coverage was initiated with a Buy rating and a price forecast of $17, with the company viewed as a strong player in the TiO2 industry due to its scale and vertical integration [3] - Improving TiO2 market fundamentals and potential anti-dumping duties on Chinese exports are expected to drive above-market volume growth and earnings upside [4] - Estimated EBITDA for 2024 is $563 million, for 2025 is $694 million (+6% vs. Street), and for 2026 is $802 million (+6% vs. Street) [4] Group 3: Minerals Technologies Inc. (MTX) - Coverage was initiated with a Buy rating and a price forecast of $103, highlighting the company's unique mineral reserves and engineering expertise as competitive advantages [5] - Sustainable mid-single-digit revenue growth is expected, with modest upside to consensus estimates for 2025-2026 [6] - Estimated EBITDA for 2024 is $404 million, for 2025 is $440 million (+3% vs. Street), and for 2026 is $471 million (+4% vs. Street) [6] Group 4: Westlake Corporation (WLK) - Analyst initiated coverage with a Buy rating and a price forecast of $168, noting the company's position as a vertically integrated market leader [7] - A strong cash balance of approximately $3 billion provides flexibility for further expansion through M&A or increased shareholder returns [7] - Estimated EBITDA for 2024 is $2.377 billion, for 2025 is $2.677 billion (+5% vs. Street), and for 2026 is $2.996 billion (+5% vs. Street) [8]

The Chemours Company (CC) recently announced that the PCC Group intends to build and operate a chlor-alkali facility on the grounds of Chemours' titanium dioxide (TiO2) plant in DeLisle, MS. Chemours and PCC have signed a chlorine supply agreement subject to certain customary conditions. The new plant will use cutting-edge technology to maximize energy efficiency and will have an annual nameplate capacity of 340,000 metric tons once operational. PCC will sell the co-product and caustic soda to key partners ...

A month has gone by since the last earnings report for Chemours (CC) . Shares have added about 8.8% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Chemours due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Chemours' Earnings and Revenues Surpass Estimates in Q3Chem ...

The Chemours Company (NYSE: CC ), a global performance chemical manufacturer, with strong clout in titanium dioxide (TiO 2) pigments (mainly used to facilitate whiteness and opacity across various applications), has proven to be a source of massive wealthAnalyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not ...

Key TakeawaysThe Chemours Company reported earnings of 40 cents a share, beating estimates of 32 cents.Shares of CC are down nearly 20% this past year, compared to the total chemical industry’s 8.3% rise.Register now to see our 7 Best Stocks for the Next 30 Days report – free today!The Chemours Company (CC) recorded a loss of $27 million or 18 cents per share in third-quarter 2024. This compares to a profit of $12 million or 8 cents in the year-ago quarter. Barring one-time items, earnings came in at 40 cen ...

Financial Data and Key Metrics Changes - Consolidated net sales for Q3 2024 were approximately $1.5 billion, up 1% year-over-year, driven by a 5% increase in volume, partially offset by a 3% decline in pricing [10][11] - Adjusted EBITDA decreased slightly from $211 million in the previous year to $208 million this quarter, primarily due to lower pricing [11] - The company reported a net loss of $27 million or $0.18 per diluted share compared to net income of $12 million or $0.08 per share in the prior year [13][14] Business Segment Performance - TSS achieved record net sales of approximately $460 million, a 6% increase from the prior year, driven by an 8% rise in volume [15] - TT's net sales fell 2% year-over-year to $679 million, primarily due to a 2% reduction in pricing, while adjusted EBITDA increased 23% to $85 million [17] - APM reported net sales of $348 million, a 1% increase compared to the prior year, driven by a 9% rise in volume, but adjusted EBITDA decreased 43% to $39 million [18] Market Data and Key Metrics Changes - The TSS business saw a robust 21% year-over-year increase in Opteon Refrigerants, which accounted for nearly 60% of total TSS refrigerant sales for the quarter [7] - The TT segment's adjusted EBITDA margin improved by 3 percentage points to 13% due to cost savings from the TT Transformation Plan [17] - APM's adjusted EBITDA margin fell 9 percentage points to 11%, primarily driven by cost mix combined with lower absorption [18] Company Strategy and Industry Competition - The company outlined a refreshed corporate strategy called "Pathway to Thrive," focusing on operational excellence, enabling growth, portfolio management, and strengthening the long term [36] - The strategy aims for a greater than 5% revenue CAGR from 2024 through 2027, targeting high-growth markets such as data center cooling and semiconductor fabrication [38] - The company plans to delay investments in the hydrogen market due to near-term weakness, while continuing to focus on high-return, low-risk initiatives [39][40] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in meeting customer demand due to stability in the macro environment and strong operational execution [6] - For Q4, TSS is expected to experience a sequential decline in net sales in the low teens, while continued double-digit growth in Opteon Refrigerants is anticipated [24] - The company expects adjusted EBITDA margins to remain around 30% or greater, assuming stable Freon pricing [27] Other Important Information - The company reported consolidated gross debt of $4.1 billion with approximately $1.2 billion in liquidity as of September 30, 2024 [20] - The company has made substantial progress on control issues, successfully remediating two of four material weaknesses as of Q3 [23] Q&A Session Summary Question: How long will higher levels of inventories of HFCs last and what pricing drag is expected moving into '25? - Management indicated that current HFC pricing levels are expected to persist into '25 due to inventory dynamics [49][50] Question: How do you see utilization rates evolving in TT moving into '25? - Management noted that while there is no significant market recovery, interest rate reductions could positively impact demand [51][52] Question: What are the expectations for TSS margins in 2025? - Management expects margins to remain above 30%, with various factors influencing pricing and costs [55][56] Question: What prompted the timing of the APM goodwill impairment? - The impairment was triggered by a strategic review of investments, particularly in the hydrogen market, which showed delayed future cash flows [60][61] Question: How does the company view the role of the TT business in the portfolio? - Management believes that the TT business remains valuable due to its cash generation capabilities and synergies with other segments [63][64] Question: What is the outlook for Freon pricing and demand? - Management noted that Freon prices are expected to remain low, influenced by inventory levels and regulatory transitions [66][71] Question: How has the corporate strategy shifted priorities compared to the last three years? - Management emphasized a disciplined approach to capital allocation, focusing on high-return investments while managing legacy liabilities [75]

Third Quarter 2024 Earnings Presentation November 4, 2024 Safe Harbor Statement and Other Matters 2 This presentation contains forward-looking statements, within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, which involve risks and uncertainties. Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to a historical or current fact. The wor ...

分组1 - Chemours reported quarterly earnings of $0.40 per share, exceeding the Zacks Consensus Estimate of $0.32 per share, but down from $0.64 per share a year ago, representing a 25% earnings surprise [1] - The company posted revenues of $1.5 billion for the quarter ended September 2024, surpassing the Zacks Consensus Estimate by 5.32% and slightly up from $1.49 billion year-over-year [2] - Chemours has surpassed consensus EPS estimates three times over the last four quarters and topped consensus revenue estimates two times in the same period [2] 分组2 - The stock has underperformed, losing about 43.5% since the beginning of the year compared to the S&P 500's gain of 20.1% [3] - The current consensus EPS estimate for the coming quarter is $0.30 on revenues of $1.35 billion, and for the current fiscal year, it is $1.32 on revenues of $5.7 billion [7] - The Zacks Industry Rank for Chemical - Diversified is currently in the bottom 20% of over 250 Zacks industries, indicating potential underperformance compared to higher-ranked industries [8]

Financial Performance - Net sales for Q3 2024 increased by $14 million (or 1%) to $1.5 billion compared to Q3 2023, driven by a 5% increase in volume, despite a 3% decrease in price and a 1% unfavorable currency impact [300]. - For the nine months ended September 30, 2024, net sales decreased by $278 million (or 6%) to $4.4 billion, primarily due to a 5% decrease in price and a 1% headwind from the sale of the Glycolic Acid business in 2023 [301]. - The Thermal & Specialized Solutions segment's net sales increased by $24 million (6%) to $460 million for the three months ended September 30, 2024, compared to $436 million for the same period in 2023 [321]. - The Titanium Technologies segment's net sales decreased by $11 million (2%) to $679 million for the three months ended September 30, 2024, compared to $690 million for the same period in 2023 [327]. - For the nine months ended September 30, 2024, segment net sales decreased by $133 million (12%) to $985 million, down from $1.1 billion in the same period in 2023 [335]. - Net sales for the nine months ended September 30, 2024, were $3.1 billion, with a gross profit of $428 million and net income of $27 million [378]. Cost and Expenses - Cost of goods sold (COGS) remained flat at $1.2 billion for Q3 2024, while COGS for the nine months decreased by $105 million (or 3%) to $3.5 billion, attributed to lower raw materials costs [303]. - Selling, general, and administrative (SG&A) expenses decreased by $30 million (or 18%) to $135 million for Q3 2024, and by $651 million (or 61%) to $416 million for the nine months, mainly due to reduced litigation-related charges [304]. - Research and development (R&D) expenses were relatively stable at $29 million for Q3 2024 and $83 million for the nine months, compared to $28 million and $82 million in the same periods of 2023 [305]. - Corporate and Other costs increased by $3 million (6%) to $57 million for the three months ended September 30, 2024, compared to $54 million in the same period in 2023 [338]. Impairments and Charges - The company recorded a non-cash goodwill impairment charge of $56 million in Q3 2024 for the Advanced Performance Materials reporting unit [294]. - A goodwill impairment charge of $56 million was recognized for the Advanced Performance Materials reporting unit for the three and nine months ended September 30, 2024 [308]. - The company recorded non-cash asset-related charges of $25 million in Q3 2024 related to the write-off of certain operating assets as part of strategic footprint transformation initiatives [385]. - Restructuring, asset-related, and other charges decreased by $81 million (or 64%) to $45 million for Q3 2024, and by $89 million (or 63%) to $52 million for the nine months, primarily due to the 2024 Restructuring Program [306]. Cash Flow and Liquidity - As of September 30, 2024, total unrestricted cash and cash equivalents were $596 million, with $394 million held by foreign subsidiaries [342]. - The availability under the Revolving Credit Facility as of September 30, 2024, was $652 million, net of $49 million in outstanding letters of credit [342]. - For the nine months ended September 30, 2024, the company incurred a net cash usage of $771 million in operating activities, compared to a cash provided of $74 million in the same period of 2023 [346]. - The company utilized supply chain financing to accelerate the collection of $40 million and $95 million in accounts receivable for the quarters ended September 30, 2024 and 2023, respectively [349]. - The company expects to fund significant cash payments for known obligations through cash generated from operations and existing debt financing arrangements [352]. Environmental and Sustainability Commitments - The company is committed to sustainability and has set ambitious Corporate Responsibility Commitment goals to achieve by 2030, focusing on reducing greenhouse gas emissions and environmental impact [292]. - The company aims for a 60% reduction in Scope 1 and Scope 2 absolute GHG emissions by 2030, aligning with its Environmental Leadership goals [426]. - Chemours has set a target to achieve net zero greenhouse gas emissions from its operations by 2050, with near-term science-based targets approved by the Science Based Targets initiative (SBTi) [427]. - The company expects to spend approximately $160 million over the next three years on the five most significant remediation sites, which represent 80% of total accrued liabilities [402]. Foreign Currency and Interest Rate Management - As of September 30, 2024, the company had 9 foreign currency forward contracts outstanding with an aggregate gross notional U.S. dollar equivalent of $153 million, with a fair value of less than $1 million [443]. - The company recognized a net gain of $1 million and a net loss of $5 million for the three and nine months ended September 30, 2024, respectively, related to non-designated foreign currency forward contracts [443]. - The company entered into interest rate swaps with an aggregate notional U.S. dollar equivalent of $300 million, with a fair value of negative $8 million as of September 30, 2024 [447]. - Pre-tax losses of $6 million and less than $1 million were recognized for the three and nine months ended September 30, 2024, respectively, related to interest rate swaps [447]. Remediation and Legal Matters - The company has $567 million in environmental remediation liabilities as of September 30, 2024, with $119 million classified as current liabilities [352]. - Fayetteville Works has been under investigation for PFAS releases, with a Consent Order in place requiring the company to provide permanent replacement drinking water supplies to affected residents [409]. - The estimated potential liabilities for environmental remediation may range up to approximately $710 million above the accrued amount as of September 30, 2024, reflecting inherent uncertainties in evaluations [397]. - The U.S. Smelter and Lead Refinery site in East Chicago, Indiana, is under EPA-directed remediation, with the company cooperating with multiple parties [413].